Siva Samy

Dr. Siva Samy is the founder, CEO, and Chief Product Strategist of ValGenesis, the global leader in digital validation lifecycle management for the life sciences industry. He built the first platform to fully digitize and automate the pharmaceutical validation process - the compliance-critical system that ensures every drug, device, and biotech product is manufactured correctly. Under his leadership, ValGenesis has become trusted by 30 of the top 50 global life sciences companies and has raised over $40 million in funding, including a $24M investment from Morgan Stanley Expansion Capital and a $16M debt financing in 2025.